【2h】

Letter to the Editor: A Patient Perspective

机译:致编辑的信:患者的观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We are 250 million souls with chronic obstructive pulmonary disease (COPD) worldwide. It’s the third leading cause of death globally. In the United States alone, we are 30 million and the third leading cause of death among chronic diseases. I have been diagnosed for 18 years with severe and very severe COPD, but COPD took decades to reveal itself in my lungs. Too many COPD patients feel abandoned, alone, fearful, anxious, and depressed, as we descend deeper and deeper in the downward spiral that has only one ending– death. Only 3 major therapies for COPD exist– inhaled medications that control symptoms for most, supplemental oxygen (only if our resting oxygen level is very low) and pulmonary rehabilitation (PR). PR is evidence-based and is a program that can and does improve our function and quality of life. It is not widely available and is dismally reimbursed. Only 1.8%–3.7% of patients have access to PR. There is presently no cure for COPD, nothing to stop the progress of the disease or to reverse it. Ironically, we have a therapy (PR) and we are not supporting its use as we should.
机译:全球有2.5亿人患有慢性阻塞性肺疾病(COPD)。它是全球第三大死亡原因。仅在美国,我们就是3000万,是慢性疾病中第三大死亡原因。我被诊断出患有严重和非常严重的COPD已经18年了,但是COPD花费了数十年才在我的肺部暴露出来。随着我们在只有一个死亡终点的下降螺旋中越陷越深,太多的COPD患者会感到被抛弃,孤独,恐惧,焦虑和沮丧。仅存在3种用于COPD的主要疗法-控制大多数症状的吸入药物,补充氧气(仅当我们的静息氧气水平非常低时)和肺部康复(PR)。 PR是基于证据的,是可以并且确实可以改善我们的功能和生活质量的程序。它没有广泛使用,因此报销不佳。只有1.8%–3.7%的患者可以获得PR。目前尚无治愈COPD的方法,也没有阻止疾病进展或逆转疾病的方法。具有讽刺意味的是,我们有一种疗法(PR),但我们并不支持这种疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号